Biotrends

Navojoa, Mexico Founded: 1998 • Age: 28 yrs
Provides comprehensive biopharma consulting services to support industry needs.
Annual revenue $855,771 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Biotrends

Biotrends is a company based in Navojoa (Mexico) founded in 1998. It operates as a B2B. Biotrends operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.

  • Headquarter Navojoa, Mexico
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Biotrends India Private Limited
  • Date of Incorporation 26 Dec, 2019
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $855.77 K (USD)
    16.27
    as on Mar 31, 2023
  • Net Profit
    $42.55 K (USD)
    7.17
    as on Mar 31, 2023
  • EBITDA
    $76.43 K (USD)
    476.84
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Biotrends

Premium access

Detailed funding history for Biotrends

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Biotrends

Investments
Premium access

Investment portfolio details for Biotrends

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Biotrends

Premium access

Detailed financials for Biotrends

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Biotrends Comparisons

Biotrends Primary company
Description
Provides comprehensive biopharma consulting services to supp...
Location
Navojoa, Mexico
Founded Year
1998
Annual Revenue
$855.77 K (USD)
Net Profit
$42.55 K (USD)
EBITDA
$76.43 K (USD)
Employees
Not available
Premium access

Peer comparison for Biotrends

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Biotrends

Biotrends operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Suite solutions are provided for payers and healthcare providers.
Locked Locked Locked
Inventory, order and customer relationship management solution for life science suppliers.
Locked Locked Locked
Specialty medicines are supplied via clinical trials and access programs.
Locked Locked Locked
Healthcare access in Asia is enhanced by Zuellig Pharma.
Locked Locked Locked
Technology-based consultancy and product development services are provided.
Locked Locked Locked
Strategic consulting services are provided to life sciences companies.
Premium access

Detailed competitors of Biotrends

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Biotrends

Premium access

Complete news archive for Biotrends

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biotrends

Biotrends was founded in 1998.

Biotrends is headquartered in Navojoa, Mexico. It is registered at Navojoa, Sonora, Mexico.

Annual revenue of Biotrends is $855.77K as on Mar 31, 2023.

Biotrends, established in 1998 and currently in Dissolved stage, focuses on providing healthcare solutions, biopharmaceuticals, offering consulting services, and biopharma advisory. Provides comprehensive biopharma consulting services to support industry needs. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

Biotrends's top competitors include Indegene, Zuellig Pharma and IntegriChain.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available